Genovis AB (publ.) (STO:GENO)
22.75
-0.65 (-2.78%)
Nov 20, 2026, 5:29 PM CET
Genovis AB (publ.) Revenue
Genovis AB (publ.) had revenue of 39.94M SEK in the quarter ending September 30, 2026, with 38.76% growth. This brings the company's total for the last twelve months to 156.02M, up 26.95% year-over-year. In the year 2025, Genovis AB (publ.) had annual revenue of 132.83M, down -12.00%. That makes Genovis AB (publ.) the 35,737th largest company in the world by revenue and 481st in Sweden.
Revenue (ttm)
156.02M
Revenue Growth
+26.95%
P/S Ratio
10.57
Revenue / Employee
3.38M
Employees
43
Market Cap
1.53B
Revenue by Geography
- Rest of World 126.49M 98.1%
- Sweden 2.46M 1.9%
Fiscal year ended Dec 31, 2025 See the full Genovis AB (publ.) breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 132.83M | -18.11M | -12.00% |
| Dec 31, 2024 | 150.93M | -14.02M | -8.50% |
| Dec 31, 2023 | 164.95M | 54.82M | 49.77% |
| Dec 31, 2022 | 110.13M | 13.88M | 14.42% |
| Dec 31, 2021 | 96.25M | 30.61M | 46.62% |
| Dec 31, 2020 | 65.65M | 2.63M | 4.17% |
| Dec 31, 2019 | 63.02M | 25.84M | 69.51% |
| Dec 31, 2018 | 37.18M | 12.97M | 53.58% |
| Dec 31, 2017 | 24.21M | -554.43K | -2.24% |
| Dec 31, 2016 | 24.76M | 2.07M | 9.12% |
| Dec 31, 2015 | 22.69M | 12.66M | 126.17% |
| Dec 31, 2014 | 10.03M | -235.55K | -2.29% |
| Dec 31, 2013 | 10.27M | 3.17M | 44.73% |
| Dec 31, 2012 | 7.10M | 3.50M | 97.28% |
| Dec 31, 2011 | 3.60M | -367.47K | -9.27% |
| Dec 31, 2010 | 3.96M | 3.71M | 1,476.49% |
| Dec 31, 2006 | 251.45K | 51.45K | 25.72% |
| Dec 31, 2005 | 200.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Saniona AB | 424.56M |
| Hansa Biopharma AB | 301.64M |
| Oncopeptides AB | 103.50M |
| Medivir AB | 8.51M |
| Xspray Pharma AB | 7.19M |
| Vicore Pharma Holding AB | 3.83M |
| Flerie AB | 2.60M |
| FluoGuide | 404.33K |
Genovis AB (publ.) News
- 12 days ago - Genovis AB (publ.) Quarterly report: Q3 2026 - Filings
- 4 months ago - Genovis AB (publ.) Quarterly report: Q2 2026 - Filings
- 6 months ago - Genovis AB (publ.) Quarterly report: Q1 2026 - Filings
- 9 months ago - Genovis AB (publ.) Quarterly report: Q4 2025 - Filings
- 9 months ago - Genovis AB (publ.) Annual report: Q4 2025 - Filings
- 2 years ago - Genovis AB (OSTO:GENO) Q3 2024 Earnings Report Preview: What to Expect - GuruFocus